Association study of interferon-γ, cytosolic phospholipase A2, and cyclooxygenase-2 gene polymorphisms in Alzheimer disease

American Journal of Geriatric Psychiatry

Volumn 18, Issue 11, 2010, Pages 983-987

  Fehér, Ágnes ^a   Juhász, Anna ^a   Rimanóczy, Ágnes ^a   Kálmán, János ^a   Janka, Zoltán ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer disease; cyclooxygenase 2; cytosolic phospholipase A2; Interferon ; single nucleotide polymorphism

Indexed keywords

ALANINE; CYCLOOXYGENASE 2; CYSTEINE; GAMMA INTERFERON; GLYCINE; PHOSPHOLIPASE A2; THREONINE;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE;

EID: 78149280715     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181e70c05     Document Type: Article

References (21)

1. Lukiw WJ, Bazan NG: Neuroinflammatory signaling upregulation in Alzheimer's disease. Neurochem Res 2000;25:1173-1184
2. Heneka MT, O'Banion MK: Inflammatory processes in Alzheimer's disease. J Neuroimmunol 2007;184:69-91
3. Wan Y, Wang G, Chen SD: Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease. Neurosci Bull 2008;24:314-322
4. Blasko I, Ransmayr G, Veerhuis R, et al: Does IFNgamma play a role in neurodegeneration? J Neuroimmunol 2001;116:1-4
5. Bate C, Kempster S, Last V, et al: Interferon-gamma increases neuronal death in response to amyloid-beta1-42. J Neuroinflammation 2006;3:7
6. Pravica V, Perrey C, Stevens A, et al: A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61:863-866
7. Scola L, Licastro F, Chiappelli M, et al: Allele frequencies of +874T→A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients. Aging Clin Exp Res 2003;15:292-295
8. Galimberti L, Arosio B, Calabresi C, et al: +874 (T→A) single nucleotide gene polymorphism does not represent a risk factor for Alzheimer's disease. Immun Ageing 2004;1:6
9. Wei J, Hemmings GP: A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia. Prostaglandins Leukot Essent Fatty Acids 2004;70:413-415
10. Papafili A, Hill MR, Brull DJ, et al: Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002;22:1516-1518
11. Abdullah L, Ait-Ghezala G, Crawford F, et al: The cyclooxygenase 2-765 C promoter allele is a protective factor for Alzheimer's disease. Neurosci Lett 2006;395:240-243
12. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944
13. Raitala A, Pertovaara M, Karjalainen J, et al: Association of interferon-gamma +874 (T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals. Scand J Immunol 2005;61:387-390
14. Chowdari KV, Brandstaetter B, Semwal P, et al: Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples. Psychiatr Genet 2004;11:207-212
15. Cipollone F, Toniato E, Martinotti S, et al: Identification of New Elements of Plaque Stability (INES) Study Group. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004;291:2221-2228
16. Hoozemans JJ, Rozemuller JM, van Haastert ES, et al: Cyclooxygenase-1 and-2 in the different stages of Alzheimer's disease pathology. Curr Pharm Des 2008;14:1419-1427
17. McGeer PL, McGeer EG: NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 2007;28:639-647
18. Landi F, Cesari M, Onder G, et al: Non-steroidal anti-inflammatory drug (NSAID) use and Alzheimer disease in community-dwelling elderly patients. Am J Geriatr Psych 2003;11:179-185
19. Small GW, Siddarth P, Silverman D H S, et al: Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. Am J Geriatr Psych 2008;16:999-1009
20. Liu F, Arias-Vásquez A, Sleegers K, et al: A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet 2007;81:17-31
21. Butler AW, Ng MY, Hamshere ML, et al: Meta-analysis of linkage studies for Alzheimer's disease-a web resource. Neurobiol Aging 2009;30:1037-1047